SCHEDULE 13G: Pacer Funds and Affiliates Disclose 6.93% Stake in Pacira BioSciences
Beneficial Ownership Report
Pacer US Small Cap Cash Cows ETF, Pacer Advisors, Inc., and Joe M. Thomson have jointly disclosed a beneficial ownership of 6.93% in Pacira BioSciences, Inc. as of December 31, 2024.
Summary
- Pacer US Small Cap Cash Cows ETF, Pacer US Small Cap Cash Cows Growth Leaders ETF, Pacer Advisors, Inc., and Joe M. Thomson (collectively, the "Reporting Persons") have filed a Schedule 13G.
- The Reporting Persons collectively beneficially own 3,262,837 shares of Common Stock of Pacira BioSciences, Inc.
- This ownership represents 6.93% of Pacira BioSciences, Inc.'s common stock outstanding.
- The percentage is calculated based on 47,077,844 shares of common stock issued and outstanding as of December 31, 2024, as reported by the Issuer.
- Pacer Advisors, Inc. serves as the investment adviser to the Funds and maintains discretionary investment and voting authority over the shares.
- Joe M. Thomson, as the majority stockholder of Pacer Advisors, Inc., is deemed a beneficial owner of these shares.
- The Reporting Persons certify that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The document is a standard beneficial ownership disclosure (Schedule 13G), indicating a passive investment stake. It does not contain information that would inherently suggest a positive or negative sentiment regarding the issuer's performance or prospects, as its primary purpose is to report ownership.
Risks
- The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating immediate control-related risks from this specific filing.
Future Outlook
NA
Management Comments
- Joe M. Thomson, Chairman and President of Pacer US Small Cap Cash Cows ETF and Pacer US Small Cap Cash Cows Growth Leaders ETF, and President of Pacer Advisors, Inc., certified that the information set forth in the statement is true, complete, and correct.
Industry Context
This filing reflects a passive investment by an investment adviser and its associated ETFs in a biotechnology company, which is a common occurrence in the asset management industry as funds build diversified portfolios. The specific focus on 'Small Cap Cash Cows' suggests an investment strategy targeting companies with strong cash flow generation within the small-cap segment.
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional stake (6.93%) provides transparency regarding the ownership structure and may be viewed positively as a vote of confidence from a large investor, although the filing explicitly states the investment is passive and not for control purposes.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement, indicating the beneficial ownership position as of this date. |
| 05/02/2025 | Date the Schedule 13G filing was signed and submitted to the SEC. |
Keywords
Pacira BioSciences, Pacer US Small Cap Cash Cows ETF, Pacer Advisors Inc., Joe M. Thomson, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.